REQUEST A DEMO
Total
USD $0.00
Search more companies

Egis Slovakia Spol. S R.O. (Slovakia)

Main Activities: Wholesale Trade Agents and Brokers
Full name: Egis Slovakia Spol. S R.O. Profile Updated: October 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

EGIS PLC is one of the leading, vertically integrated pharmaceutical companies in Central Eastern Europe with activities extending to every field of pharmaceutical production from generic and original R&D, through active ingredient and finished production to sales and marketing. Currently the company has commercial offices and trading companies in 18 countries. On January 1, 1997 EGIG SLOVAKIA transformed to legal subject and operates on slovak pharmaceutical market as EGIS SLOVAKIA s.r.o., a major importer of EGIS Pharmaceutical Ltd., Budapest products.

Headquarters
Prievozska, 4D
Bratislava; Bratislavsky; Postal Code: 82109

Contact Details: Purchase the Egis Slovakia Spol. S R.O. report to view the information.

Website: http://www.egis.sk

Basic Information
Total Employees:
Purchase the Egis Slovakia Spol. S R.O. report to view the information.
Outstanding Shares:
Purchase the Egis Slovakia Spol. S R.O. report to view the information.
Registered Capital:
Purchase the Egis Slovakia Spol. S R.O. report to view the information.
Incorporation Date:
October 14, 1996
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Egis Slovakia Spol. S R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
9.35%
Total operating revenue
10.72%
Operating profit (EBIT)
38.31%
EBITDA
21.24%
Net Profit (Loss) for the Period
29.83%
Total assets
22.05%
Total equity
1.38%
Operating Profit Margin (ROS)
0.92%
Net Profit Margin
0.4%
Return on Equity (ROE)
1.12%
Debt to Equity Ratio
0.07%
Quick Ratio
-0.49%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?